Phospho-TP53BP1 (S25) Antibody

Basic Research Questions

• What is Phospho-TP53BP1 (S25) Antibody and what does it detect?

  Phospho-TP53BP1 (S25) antibody specifically recognizes the p53-binding protein 1 (53BP1) when phosphorylated at serine 25. This phosphorylation is primarily catalyzed by the ATM checkpoint kinase in response to DNA damage. The antibody is designed to detect endogenous levels of 53BP1 only when phosphorylated at this specific residue, making it a valuable tool for studying DNA damage response pathways. Most commercially available antibodies are developed using synthetic phosphopeptides derived from human 53BP1 around the phosphorylation site of S25 . These antibodies typically show reactivity with human samples, and some cross-react with mouse and rat samples .

• What are the primary applications for Phospho-TP53BP1 (S25) Antibody?

  Phospho-TP53BP1 (S25) antibody can be used in multiple experimental approaches:

  Application	Recommended Dilution	Detection Method
  Western Blotting	1:1000	HRP-conjugated secondary antibody
  Immunofluorescence	1:100 - 1:1000	Fluorophore-conjugated secondary antibody
  ELISA	1:10000	Enzyme-conjugated detection system
  Immunohistochemistry	1:100 - 1:300	Chromogenic or fluorescent detection
  Dot Blot	1:1000	HRP-conjugated secondary antibody

  For Western blotting, the antibody detects a specific band for phosphorylated 53BP1 at approximately 450 kDa. The phospho-specificity can be validated by decreased labeling following treatment with lambda-phosphatase . When used for immunofluorescence, the antibody can visualize nuclear foci of phosphorylated 53BP1 at sites of DNA damage .

• What specific controls should be used when working with Phospho-TP53BP1 (S25) Antibody?

  To ensure experimental validity when using Phospho-TP53BP1 (S25) antibody, incorporate these controls:

  • Positive control: Lysates from cells exposed to DNA damaging agents (e.g., K562 human leukemia cells treated with 50 J/m² UV-C with 1 hour recovery time)

  • Negative control: Untreated cell lysates where basal phosphorylation is minimal

  • Phosphatase treatment control: Treating a portion of your positive control sample with lambda phosphatase (λ-PPase) to demonstrate phospho-specificity

  • Knockout/knockdown control: Samples from 53BP1 knockout or knockdown cells to confirm antibody specificity

  • Peptide competition assay: Pre-incubating the antibody with the phosphopeptide immunogen to block specific binding

  These controls collectively verify that your antibody is specifically detecting phosphorylated S25 on 53BP1 rather than cross-reacting with other phosphoproteins or unphosphorylated 53BP1.

• What is the expected molecular weight of phosphorylated 53BP1 in Western blot?

  While the predicted molecular weight of 53BP1 is approximately 213-214 kDa, it consistently appears at a much higher molecular weight in Western blot analyses. Most research findings demonstrate that phosphorylated 53BP1 migrates at approximately 450 kDa . This significant discrepancy between predicted and observed molecular weights is commonly noted across different commercial antibodies and is not limited to particular vendor products . The substantially higher apparent molecular weight is likely due to post-translational modifications, including extensive phosphorylation at multiple sites, and the protein's large size affecting its migration pattern in SDS-PAGE. Researchers should be aware of this characteristic migration pattern when analyzing Western blot results.

• How should Phospho-TP53BP1 (S25) Antibody be stored and handled for optimal performance?

  Proper storage and handling are critical for maintaining antibody activity:

  • Long-term storage: Store at -20°C for up to one year

  • Working solution: For frequent use, store at 4°C for up to one month

  • Storage buffer: Typically supplied in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide

  • Avoid repeated freeze-thaw cycles: Aliquot the antibody upon first thaw to minimize freeze-thaw cycles

  • Working dilutions: Prepare working dilutions fresh before use and discard after experiments

  • Temperature considerations: Keep antibodies on ice during experiment preparation

  Following these guidelines ensures maximum antibody performance and extends shelf life. Always refer to manufacturer-specific instructions, as formulations may vary slightly between vendors.

Advanced Research Questions

• How does phosphorylation at S25 affect 53BP1 function in DNA damage response pathways?

  Phosphorylation of 53BP1 at S25 serves as a critical regulatory mechanism in the DNA damage response:

  • It mediates the interaction between 53BP1 and PTIP (Pax transactivation domain-interacting protein)

  • This interaction is essential for promoting DNA double-strand break (DSB) end protection

  • S25 phosphorylation plays a key role in pathological injury repair pathway selection

  • It contributes to telomere fusion processes

  • Phosphorylation at S25 works in concert with other phosphorylation events on 53BP1 to coordinate the recruitment of downstream effector proteins

  Mechanistically, when DNA damage occurs, ATM kinase phosphorylates 53BP1 at S25, facilitating its interaction with PTIP. This creates a phospho-dependent binding platform that helps determine whether DNA repair proceeds via non-homologous end joining (NHEJ) rather than homologous recombination (HR). The phosphorylation status at S25 therefore acts as a molecular switch that influences DNA repair pathway choice, with profound implications for genomic stability maintenance .

• What is the relationship between ATM kinase and 53BP1 S25 phosphorylation in different cellular contexts?

  The ATM-mediated phosphorylation of 53BP1 at S25 occurs in various cellular contexts with context-specific functions:

  • DNA damage response: ATM rapidly phosphorylates 53BP1 at S25 following DNA double-strand breaks, promoting 53BP1 recruitment to damage sites and facilitating interaction with PTIP

  • Neural development: ATM-dependent phosphorylation of 53BP1-S25 is crucial for proper expression of genetic programs during the growth and development of cortical brain organoids. This phosphorylation controls 53BP1's binding to genomic targets functioning in neuronal differentiation, cytoskeleton organization, and various signaling pathways including p53, ATM, BDNF, and WNT

  • Cell cycle regulation: While 53BP1 protein levels remain relatively constant throughout the cell cycle, its phosphorylation at S25 is dynamically regulated and affects its genomic localization patterns

  • Gene expression regulation: 53BP1-S25 phosphorylation impacts 53BP1's binding to bivalent or H3K27me3-occupied promoters, particularly at genes regulating H3K4 methylation, neuronal functions, and cell proliferation

  Interestingly, while ATM is the primary kinase responsible for S25 phosphorylation after DNA damage, vaccinia-related kinase 1 (VRK1) can also phosphorylate 53BP1 at S25/29 even without ATM activity. The VRK1-mediated phosphorylation is involved in the formation of γH2AX, NBS1, and 53BP1 foci in NHEJ repair and regulates cell cycle entry into the G2/M phase .

• How can researchers distinguish between different phosphorylation sites on 53BP1?

  53BP1 contains multiple phosphorylation sites that serve different functions in the DNA damage response. Researchers can distinguish between these sites using:

  1. Site-specific phospho-antibodies: Use antibodies that specifically recognize distinct phosphorylation sites such as:

     • Phospho-53BP1 (S25) antibody

     • Phospho-53BP1 (T543) antibody

     • Phospho-53BP1 (S25/29) antibody

     • Phospho-53BP1 (S1778) antibody

  2. Phospho-mutant expression: Generate site-specific phosphorylation mutants (S→A or S→E) to assess the functional impact of specific sites

  3. Mass spectrometry analysis: Perform phospho-proteomics to map and quantify all phosphorylation sites simultaneously

  4. Functional assays: Assess the interaction with specific binding partners that depend on particular phosphorylation sites:

     • S25 phosphorylation → interaction with PTIP

     • T302, S437, S452, S523, S543, S580, S625 phosphorylation → interaction with RIF1

  The comprehensive table from search result provides an excellent reference for understanding the different phosphorylation sites, their catalytic enzymes, and functional effects:

  Post-transcriptional modification	Catalytic molecule	Catalytic site(s) of 53BP1	Effects	(Refs.)
  Phosphorylation	ATM	S25	Interacts with PTIP to promote DSB end protection	(56)
  ATM	T302, S437, S452, S523, S543, S580, S625	Interacts with RIF1 to inhibit DNA end resection	(55)
  VRK1 (without ATM)	S25, S29	Induces the formation of 53BP1 foci	(95,96)
  AMPK	S1317	Promotes 53BP1 recruitment to DSB sites	(97)
  GSK3β	S166	Promotes 53BP1 recruitment to DSB sites and induces DNA repair	(98)

• What are the best experimental conditions to induce and detect 53BP1 S25 phosphorylation?

  To effectively induce and detect 53BP1 S25 phosphorylation, researchers should consider the following experimental conditions:

  Induction of phosphorylation:

  • UV irradiation: Expose cells to 50 J/m² UV-C followed by 1 hour recovery time

  • Ionizing radiation: Apply gamma or X-ray radiation (2-10 Gy) with 15-60 minute recovery time

  • Radiomimetic drugs: Treat with neocarzinostatin, bleomycin, or etoposide for 1-4 hours

  • Replication stress: Apply hydroxyurea or aphidicolin treatment for 4-24 hours

  Detection optimization:

  • Lysis conditions: Use RIPA buffer supplemented with phosphatase inhibitors (sodium fluoride, sodium orthovanadate, β-glycerophosphate) and protease inhibitors

  • Sample preparation: Maintain samples at 4°C throughout processing to prevent phosphatase activity

  • Gel electrophoresis: Use low percentage gels (3-6%) or gradient gels to separate the high molecular weight 53BP1 protein (~450 kDa)

  • Transfer conditions: Employ wet transfer at low voltage (30V) overnight for efficient transfer of high molecular weight proteins

  • Blocking: Use 5% BSA in TBST rather than milk, as milk contains phosphatases that may reduce signal

  • Antibody incubation: Incubate primary antibody at 4°C overnight for optimal binding

  For immunofluorescence detection, fix cells in 4% paraformaldehyde, permeabilize with 0.5% Triton X-100, and perform antigen retrieval if necessary. Pre-extraction steps before fixation can enhance the visualization of chromatin-bound 53BP1 phosphorylated at S25.

• How does 53BP1 S25 phosphorylation differ across cell types and developmental stages?

  53BP1 S25 phosphorylation exhibits notable variations across cell types and developmental stages:

  Cell type differences:

  • Neural progenitor cells (NPCs): Elevated levels of 53BP1-pS25 compared to human embryonic stem cells (hESCs), independent of DNA damage levels

  • Cancer cell lines: Constitutive phosphorylation in some cancer lines with aberrant DNA damage response pathways

  • Immune cells: Dynamic regulation during class-switch recombination processes

  • Primary vs. transformed cells: Different baseline and induction kinetics

  Developmental regulation:

  • Neural differentiation: Markedly increased 53BP1-pS25 levels in NPCs compared to hESCs, despite similar levels of total 53BP1 and DNA damage marker γH2AX

  • Embryonic development: Stage-specific phosphorylation patterns

  • Tissue maturation: Phosphorylation patterns change during organ development

  Methodological approach to study these differences:

  1. Isolate cells from different tissues/developmental stages

  2. Perform Western blot analysis using Phospho-53BP1 (S25) antibody

  3. Normalize to total 53BP1 levels

  4. Correlate with functional assays for DNA repair capacity

  5. Use phospho-proteomics for comprehensive analysis across multiple cell types

  These differences suggest that S25 phosphorylation on 53BP1 has context-dependent regulatory mechanisms and functions beyond the canonical DNA damage response, particularly in developmental processes.

• What is the role of 53BP1 S25 phosphorylation in neural development and related disorders?

  Recent research has revealed a crucial role for 53BP1 S25 phosphorylation in neural development:

  • Neural progenitor cell regulation: Phosphorylation of 53BP1 at serine 25 by ATM is required for neural progenitor cell proliferation and neuronal differentiation in cortical brain organoids

  • Gene expression control: Dynamic phosphorylation of 53BP1-S25 controls target genes governing neuronal differentiation and function, cellular response to stress, and apoptosis

  • Chromatin binding regulation: ATM and RNF168 govern 53BP1's binding to gene loci to directly affect gene regulation, especially at genes for neuronal differentiation and maturation

  • Epigenetic modulation: 53BP1 S25 phosphorylation effectively impedes its binding to bivalent or H3K27me3-occupied promoters, especially at genes regulating H3K4 methylation, neuronal functions, and cell proliferation

  • Developmental dynamics: While 53BP1 protein levels remain constant during differentiation from hESCs to NPCs, the levels of 53BP1-pS25 increase markedly, suggesting post-translational regulation is key during neural development

  These findings establish 53BP1 S25 phosphorylation as a critical regulatory mechanism in neurogenesis and brain development. Methodologically, researchers studying this aspect should employ brain organoid models, neural differentiation protocols, ChIP-seq for genome-wide binding patterns, and correlate phosphorylation status with transcriptome changes and neuronal differentiation markers.

• How does TIRR regulation of 53BP1 interact with S25 phosphorylation status?

  The interaction between TIRR (Tudor-interacting repair regulator) and 53BP1 S25 phosphorylation represents a sophisticated regulatory mechanism:

  • TIRR binds to the Tudor domain of 53BP1, inhibiting its recruitment to DNA damage sites by preventing its recognition of H4K20me2

  • Loss of TIRR results in enhanced phosphorylation of 53BP1 at S25 and increased association with effector proteins after DNA damage induction

  • A specific mutation in 53BP1 (F1553R) disrupts TIRR binding and mimics TIRR loss, creating a "hyperactive" form of 53BP1 that shows:

    • Decreased nuclear soluble levels

    • Efficient phosphorylation at S25 and S29 in response to ionizing radiation

    • Stronger association with effector proteins like PTIP and TopBP1

    • Significantly increased mobility in cells (3x faster recovery in FRAP assays)

  This relationship suggests a coordinated regulatory circuit where:

  1. In the absence of DNA damage, TIRR binds 53BP1's Tudor domain, keeping it in a soluble, inactive state

  2. Upon DNA damage, TIRR dissociates, allowing 53BP1 to be phosphorylated at S25 by ATM

  3. Phosphorylated 53BP1 then recruits effector proteins like PTIP

  Methodologically, researchers can study this relationship using TIRR knockout/knockdown cells, the 53BP1 F1553R mutant as a TIRR-binding deficient model, and examining phosphorylation status at S25 and other sites under various DNA damage conditions.

• What methodological approaches can be used to study the dynamics of 53BP1 phosphorylation?

  To investigate the temporal and spatial dynamics of 53BP1 phosphorylation, researchers can employ several advanced methodological approaches:

  Temporal dynamics:

  • Time-course experiments: Induce DNA damage and collect samples at multiple time points (5 min, 15 min, 30 min, 1h, 4h, 24h) to track phosphorylation kinetics

  • Pulse-chase phosphorylation: Use 32P-labeling followed by immunoprecipitation of 53BP1

  • Inhibitor withdrawal studies: Apply and remove ATM inhibitors to study phosphorylation/dephosphorylation rates

  Spatial dynamics:

  • Live-cell imaging: Use fluorescent protein-tagged 53BP1 and phospho-specific antibody fragments

  • Super-resolution microscopy: Employ techniques like STORM or PALM for nanoscale localization

  • Proximity ligation assay (PLA): Detect phosphorylated 53BP1 interaction with binding partners in situ

  Functional dynamics:

  • FRAP (Fluorescence Recovery After Photobleaching): Measure mobility changes upon phosphorylation (hyperphosphorylated 53BP1 shows increased mobility with t1/2 of ~15.5 sec vs. 55.6 sec for wild-type)

  • Chromatin fractionation: Separate and analyze chromatin-bound vs. soluble phosphorylated 53BP1

  • ChIP-seq with phospho-specific antibodies: Map genome-wide binding patterns of phosphorylated 53BP1

  Quantitative analysis:

  • Mass spectrometry: Use SILAC or TMT labeling for quantitative phospho-proteomics

  • Phos-tag SDS-PAGE: Separate phosphorylated from non-phosphorylated forms

  • Automated high-content microscopy: Quantify nuclear foci formation and colocalization

  These approaches provide complementary data on how 53BP1 phosphorylation is regulated in space and time, offering insights into its dynamic functions in DNA damage response and other cellular processes.

• How can researchers validate the specificity of Phospho-TP53BP1 (S25) Antibody for critical experiments?

  For rigorous validation of Phospho-TP53BP1 (S25) antibody specificity, researchers should implement a comprehensive validation strategy:

  Biochemical validation:

  • Phosphatase treatment: Treat positive control samples with lambda phosphatase to demonstrate signal loss

  • Peptide competition: Pre-incubate antibody with phosphorylated and non-phosphorylated peptides corresponding to the S25 region

  • Western blotting: Confirm single band at expected molecular weight (~450 kDa)

  • Dot blot analysis: Compare reactivity against phosphorylated vs. non-phosphorylated peptides

  Genetic validation:

  • 53BP1 knockout models: Test for complete signal absence in 53BP1 knockout cells

  • S25A mutant: Express 53BP1 with serine-to-alanine mutation at position 25 to confirm antibody specificity

  • siRNA knockdown: Verify signal reduction proportional to protein depletion

  Functional validation:

  • ATM inhibition: Treat cells with ATM inhibitors to prevent S25 phosphorylation

  • DNA damage induction: Confirm increased signal after DNA damage treatments

  • Kinase assays: Perform in vitro kinase assays with recombinant ATM and 53BP1

  Cross-reactivity assessment:

  • Multiple cell lines: Test across different species and cell types to confirm expected reactivity

  • Other phospho-proteins: Examine cross-reactivity with other phosphorylated proteins containing similar motifs

  • Multi-antibody comparison: Compare results from antibodies from different sources detecting the same phosphorylation site

  Documentation of these validation steps should be included in publications to establish the reliability of experimental findings based on this antibody.

• What are the implications of 53BP1 S25 phosphorylation in cancer research?

  53BP1 S25 phosphorylation has significant implications for cancer research in multiple areas:

  Diagnostic potential:

  • Phosphorylated 53BP1 at S25 may serve as a biomarker for DNA damage response activation in tumors

  • Altered phosphorylation patterns could indicate defects in ATM signaling or downstream effectors

  Therapeutic targeting:

  • Cancer cells with defects in homologous recombination rely more heavily on 53BP1-dependent NHEJ

  • Modulating 53BP1 S25 phosphorylation could potentially enhance synthetic lethality approaches

  • The interaction between PTIP and phosphorylated 53BP1 at S25 represents a targetable node

  Resistance mechanisms:

  • Changes in 53BP1 phosphorylation patterns may contribute to therapy resistance

  • 53BP1 loss or phosphorylation site mutations can restore HR in BRCA1-deficient cells, causing PARP inhibitor resistance

  DNA repair pathway choice:

  • S25 phosphorylation influences repair pathway choice, with implications for genomic instability in cancer

  • Understanding this regulation may allow manipulation of repair outcomes in therapeutic contexts

  Methodological approaches:

  1. Compare 53BP1 S25 phosphorylation patterns across cancer types and stages

  2. Correlate phosphorylation status with treatment response

  3. Test pharmacological inhibitors of the ATM-53BP1 axis in combination with DNA-damaging agents

  4. Develop phospho-mimetic or phospho-dead 53BP1 variants to study functional consequences

  5. Perform synthetic lethality screens in cells with altered 53BP1 phosphorylation

  This research direction could ultimately lead to novel therapeutic strategies exploiting the DNA damage response dependencies of cancer cells.